Syed Hasan to Dipeptidyl-Peptidase IV Inhibitors
This is a "connection" page, showing publications Syed Hasan has written about Dipeptidyl-Peptidase IV Inhibitors.
Connection Strength
0.737
-
A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19. Therapie. 2021 Jul-Aug; 76(4):361-364.
Score: 0.591
-
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021 Feb; 22(2):229-240.
Score: 0.146